EUVIMEDEUVIMED entdecken
Open Access

Mechanistic insights into the therapeutic properties of delta opioid receptor

Sarah M Bernhard iD, Susovan Roy Chowdhury iD, Tsuyoshi Murata iD, Erin L Reinl iD, Nokomis Ramos-Gonzalez iD, Elizabeth Denn, Kevin Appourchaux iD, Asuka Inoue iD, Sarah K England iD, Jonathan F Fay iD, Susruta Majumdar iD, Baron Chanda iD und 1 weitere

Science Advances · 27.03.2026 · 12 (13)

DOI: 10.1126/sciadv.aeb6737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 27.03.2026. Verfasst von Sarah M Bernhard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Receptors, Opioid, delta. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health, Pharmaceutical Research and Manufacturers of America Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The delta opioid receptor (DOR) is a promising target for treating pain, anxiety, and depression, yet no DOR-based drugs have reached the clinic. Here, we examine how ligands with varying therapeutic properties modulate DOR function. While full agonists rapidly internalize the receptor, partial agonists show a slower rate of internalization, and antagonists increase cell-surface DOR levels. High-resolution structures of ligand-bound DOR-G i1 complexes, including those with antagonists engaged, reveal key interactions that account for DOR ligand selectivity, potency, and efficacy. Single-molecule fluorescence resonance energy transfer studies show that DOR dynamically samples three distinct states (active, obligate preactive, and inactive), and transition rates are tuned by both ligand efficacy and G protein coupling. The endogenous agonist, met-enkephalin, not only stabilizes the active-state conformation but also catalyzes transitions between the active and inactive states. These results reveal how ligand-specific interactions and receptor dynamics can govern pharmacological profiles and provide a framework for developing DOR-targeted therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Opioid, deltaLigandsHumansFluorescence Resonance Energy TransferProtein BindingProtein ConformationAnimalsModels, Molecular

Substanzen

Receptors, Opioid, deltaLigands

Autor:innen und Institutionen

  • Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Center for Investigation of Membrane Excitability Diseases, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Anesthesiology, Washington University in St. Louis, St. Louis, MO, USA.
  • Department of Obstetrics and Gynecology, Center for Reproductive Health Sciences, Washington University in St. Louis, St. Louis, MO, USA.
  • Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan.
  • Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.

ORCID-Profile: Sarah M Bernhard, Susovan Roy Chowdhury, Tsuyoshi Murata, Erin L Reinl, Nokomis Ramos-Gonzalez, Kevin Appourchaux, Asuka Inoue, Sarah K England, Jonathan F Fay, Susruta Majumdar, Baron Chanda, Tao Che

Förderung

  • National Institutes of Health
  • Pharmaceutical Research and Manufacturers of America Foundation
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Uehara Memorial Foundation
  • PhRMA Foundation
  • National Institute of Development Administration

Zitieren

APA

Bernhard, S. M., Roy Chowdhury, S., Murata, T., Reinl, E. L., Ramos-Gonzalez, N., Denn, E., Appourchaux, K., Inoue, A., England, S. K., Fay, J. F., Majumdar, S., Chanda, B., & Che, T. (2026). Mechanistic insights into the therapeutic properties of delta opioid receptor. Science Advances, 12(13). https://doi.org/10.1126/sciadv.aeb6737

Vancouver

Bernhard SM, Roy Chowdhury S, Murata T, Reinl EL, Ramos-Gonzalez N, Denn E, et al. Mechanistic insights into the therapeutic properties of delta opioid receptor. Science Advances. 2026;12(13). doi:10.1126/sciadv.aeb6737

BibTeX
@article{Bernhard2026,
  author = {Bernhard, Sarah M and Roy Chowdhury, Susovan and Murata, Tsuyoshi and Reinl, Erin L and Ramos-Gonzalez, Nokomis and Denn, Elizabeth and Appourchaux, Kevin and Inoue, Asuka and England, Sarah K and Fay, Jonathan F and Majumdar, Susruta and Chanda, Baron and Che, Tao},
  title = {Mechanistic insights into the therapeutic properties of delta opioid receptor},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {13},
  doi = {10.1126/sciadv.aeb6737}
}
Kostenlos starten →